Tools · Private company
Lantheus Medical Imaging
Track this companyFree. Adds Lantheus Medical Imaging to your Dealase workspace and tells you when its record changes.
Clinical trials2511 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- [68Ga]-LNTH-2401Phase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- DEFINITY®Phase 3 · Cardiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- piflufolastat F 18Phase 3 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- 64Cu-LNTH-1363SPhase 2 · Metastatic SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- LNTH2403 Phase 1 dosePhase 2 · Relapsed / Refractory OsteosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- Phase 2; LNTH2403 a single agent recommended phase 2 dose (RP2D).Phase 2 · Relapsed / Refractory OsteosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- [Lu-177]-PNT2002Castration-Resistant Prostatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- DefinityPulmonary Heart DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DEFINITY®Cardiovascular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Perflutren Lipid Microsphere Injectable SuspensionCoronary Artery DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- PYLARIFYProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)PHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07645326 · fetched Nov 12, 2026
- Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])PHASE2_PHASE3 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07831824 · fetched Nov 12, 2026
- Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck CancerPHASE1 · RECRUITING · started Mar 18, 2026ClinicalTrials.gov NCT07501650 · fetched Nov 12, 2026
- Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)PHASE1_PHASE2 · RECRUITING · started Feb 3, 2026ClinicalTrials.gov NCT07357519 · fetched Nov 12, 2026
- Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCCPHASE2_PHASE3 · WITHDRAWN · started Nov 1, 2025ClinicalTrials.gov NCT07084909 · fetched Nov 12, 2026
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerPHASE1_PHASE2 · RECRUITING · started Aug 1, 2025ClinicalTrials.gov NCT06298916 · fetched Nov 12, 2026
- Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary TumorsRECRUITING · started Jun 19, 2024ClinicalTrials.gov NCT07335315 · fetched Nov 12, 2026
- A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGRECRUITING · started Jun 7, 2024ClinicalTrials.gov NCT05160480 · fetched Nov 12, 2026
- PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate CancerPHASE4 · ACTIVE_NOT_RECRUITING · started Feb 8, 2024ClinicalTrials.gov NCT06074510 · fetched Nov 12, 2026
- An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate CancerACTIVE_NOT_RECRUITING · started May 22, 2023ClinicalTrials.gov NCT05712473 · fetched Nov 12, 2026
- A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 28, 2022ClinicalTrials.gov NCT05394259 · fetched Nov 12, 2026
- Diagnosing Compartment Syndrome With SHAPE vs ElastographyPHASE2_PHASE3 · COMPLETED · started Jul 1, 2020ClinicalTrials.gov NCT05247541 · fetched Nov 12, 2026
- Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel LindauPHASE2 · COMPLETED · started Sep 23, 2019ClinicalTrials.gov NCT03907657 · fetched Nov 12, 2026
- DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITYPHASE3 · COMPLETED · started Dec 28, 2018ClinicalTrials.gov NCT03719612 · fetched Nov 12, 2026
- DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITYPHASE3 · COMPLETED · started Oct 24, 2018ClinicalTrials.gov NCT03571672 · fetched Nov 12, 2026
- Prediction of ARrhythmic Events With Positron Emission Tomography IIACTIVE_NOT_RECRUITING · started Apr 8, 2018ClinicalTrials.gov NCT03493516 · fetched Nov 12, 2026
- Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing SurgeryEARLY_PHASE1 · COMPLETED · started Aug 1, 2017ClinicalTrials.gov NCT03297112 · fetched Nov 12, 2026
- Contrast-enhanced Ultrasound Evaluation of ChemoembolizationPHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02764801 · fetched Nov 12, 2026
- Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular CalcificationCOMPLETED · started Nov 7, 2014ClinicalTrials.gov NCT04093973 · fetched Nov 12, 2026
- Quantitative Subharmonic Breast ImagingPHASE4 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01490892 · fetched Nov 12, 2026
- A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery PressurePHASE4 · COMPLETED · started Jul 1, 2009ClinicalTrials.gov NCT00918866 · fetched Nov 12, 2026
- A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical PracticePHASE4 · COMPLETED · started Feb 1, 2008ClinicalTrials.gov NCT00625365 · fetched Nov 12, 2026
- Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm RepairCOMPLETED · started Jan 1, 2008ClinicalTrials.gov NCT01005212 · fetched Nov 12, 2026
- A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary DiseasePHASE4 · COMPLETED · started Apr 1, 2004ClinicalTrials.gov NCT00162370 · fetched Nov 12, 2026
- Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)TEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT06033001 · fetched Nov 12, 2026